Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

236.5000 USD 0.3800 0.16%

As of 20:04:05 ET on 05/28/2015.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 235.2500 High - Low: 236.9300 - 232.0800 Primary Exchange: NYSE Arca
Volume: 732,364 52-Week Range: 128.5000 - 244.9800 Beta vs SPSIBITR: 0.9987

ETF Chart for XBI

No chart data available.
  • XBI:US 236.5000
  • 1D
  • 1M
  • 1Y
236.8800
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2015-05-27) 236.7564
Assets (M) (on 2015-05-27) 2,225.5100
Shares out (M) 9.40
Market Cap (M) 2,223.10
% Premium 0.05
Average 52-Week % Premium 0.0056
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-03-20) 0.2454
Dividend Yield (ttm) 0.81%

Performance for XBI

1-Month +7.21% 1-Year +79.68%
3-Month +10.48% 3-Year +43.03%
Year To Date +27.17% 5-Year +34.72%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 05/27/2015
Name Position Value % of Total
Synageva BioPharma Corp 206,823 44,626,199 2.026%
Sarepta Therapeutics Inc 1,569,522 41,027,305 1.863%
Alder Biopharmaceuticals Inc 873,636 36,649,030 1.664%
Bluebird Bio Inc 184,754 35,045,986 1.591%
Dyax Corp 1,280,176 34,206,303 1.553%
Ultragenyx Pharmaceutical Inc 386,986 33,567,166 1.524%
Esperion Therapeutics Inc 297,657 31,498,064 1.430%
Momenta Pharmaceuticals Inc 1,487,274 29,165,443 1.324%
Amicus Therapeutics Inc 2,394,253 28,635,266 1.300%
Repligen Corp 707,320 28,561,582 1.297%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil